{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:19:55Z","timestamp":1788981595688,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100022762","name":"Universit\u00e4t Witten\/Herdecke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022762","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Society for Surgery of the Shoulder and Elbow"},{"name":"Gesellschaft f\u00fcr Arthroskopie und Gelenkchirurgie"},{"name":"Private Universit\u00e4t Witten\/Herdecke gGmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s13318-026-01009-x","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:59:21Z","timestamp":1781899161000},"page":"577-586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protein Binding of Cefazolin is Not Saturated in Human Synovial Fluid After Single-Dose Perioperative Antibiotic Prophylaxis"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9088-334X","authenticated-orcid":false,"given":"Steffen T.","family":"Ubl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8589-8183","authenticated-orcid":false,"given":"Luc M.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0373-3715","authenticated-orcid":false,"given":"Sophia","family":"Krombholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6265-9802","authenticated-orcid":false,"given":"Arasch","family":"Wafaisade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3397-5643","authenticated-orcid":false,"given":"Daniel","family":"Guenther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5048-1311","authenticated-orcid":false,"given":"Bertil","family":"Bouillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5972-8854","authenticated-orcid":false,"given":"Mario","family":"Thevis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0492-6949","authenticated-orcid":false,"given":"Thomas R.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"12","key":"1009_CR1","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/jps.2600641202","volume":"64","author":"CH Nightingale","year":"1975","unstructured":"Nightingale CH, Greene DS, Quintiliani R. Pharmacokinetics and clinical use of cephalosporin antibiotics. J Pharm Sci. 1975;64(12):1899\u2013926. https:\/\/doi.org\/10.1002\/jps.2600641202.","journal-title":"J Pharm Sci"},{"issue":"1","key":"1009_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12248-008-9072-1","volume":"11","author":"J Beer","year":"2009","unstructured":"Beer J, Wagner CC, Zeitlinger M. Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing. AAPS J. 2009;11(1):1\u201312. https:\/\/doi.org\/10.1208\/s12248-008-9072-1.","journal-title":"AAPS J"},{"issue":"3","key":"1009_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/jac\/11.3.233","volume":"11","author":"DJ Merrikin","year":"1983","unstructured":"Merrikin DJ, Briant J, Rolinson GN. Effect of protein binding on antibiotic activity in\u00a0vivo. J Antimicrob Chemother. 1983;11(3):233\u20138. https:\/\/doi.org\/10.1093\/jac\/11.3.233.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1009_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40262-012-0018-5","volume":"52","author":"JA Roberts","year":"2013","unstructured":"Roberts JA, Pea F, Lipman J. The clinical relevance of plasma protein binding changes. Clin Pharmacokinet. 2013;52(1):1\u20138. https:\/\/doi.org\/10.1007\/s40262-012-0018-5.","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"1009_CR5","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.xphs.2018.03.023","volume":"107","author":"AN Deitchman","year":"2018","unstructured":"Deitchman AN, Singh RSP, Derendorf H. Nonlinear protein binding: not what you think. J Pharm Sci. 2018;107(7):1754\u201360. https:\/\/doi.org\/10.1016\/j.xphs.2018.03.023.","journal-title":"J Pharm Sci"},{"issue":"6","key":"1009_CR6","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1365-2125.2006.02827.x","volume":"63","author":"JW Vella-Brincat","year":"2007","unstructured":"Vella-Brincat JW, et al. Protein binding of cefazolin is saturable in vivo both between and within patients. Br J Clin Pharmacol. 2007;63(6):753\u20137. https:\/\/doi.org\/10.1111\/j.1365-2125.2006.02827.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"1009_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00494-24","volume":"68","author":"R Eelsing","year":"2024","unstructured":"Eelsing R, et al. Plasma and tissue concentrations of 2 g prophylactic cefazolin prior to lower extremity surgery. Antimicrob Agents Chemother. 2024;68(7):e0049424. https:\/\/doi.org\/10.1128\/aac.00494-24.","journal-title":"Antimicrob Agents Chemother"},{"key":"1009_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.900551","volume":"13","author":"C Jongmans","year":"2022","unstructured":"Jongmans C, et al. An overview of the protein binding of cephalosporins in human body fluids: a systematic review. Front Pharmacol. 2022;13:900551. https:\/\/doi.org\/10.3389\/fphar.2022.900551.","journal-title":"Front Pharmacol"},{"issue":"4","key":"1009_CR9","doi-asserted-by":"publisher","first-page":"e02114","DOI":"10.1128\/AAC.02114-20","volume":"65","author":"T Komatsu","year":"2021","unstructured":"Komatsu T, et al. Population pharmacokinetic and pharmacodynamic target attainment analysis of cefazolin in the serum and hip joint capsule of patients undergoing total hip arthroplasty. Antimicrob Agents Chemother. 2021;65(4):e02114-20. https:\/\/doi.org\/10.1128\/AAC.02114-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"1009_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118150","volume":"188","author":"J Scala-Bertola","year":"2025","unstructured":"Scala-Bertola J, et al. Population pharmacokinetics of cefazolin in neurosurgical antibiotic prophylaxis. Biomed Pharmacother. 2025;188:118150. https:\/\/doi.org\/10.1016\/j.biopha.2025.118150.","journal-title":"Biomed Pharmacother"},{"key":"1009_CR11","volume-title":"Guideline on bioanalytical method validation","author":"EM Agency","year":"2011","unstructured":"Agency EM. Guideline on bioanalytical method validation. London: European Medicines Agency; 2011."},{"issue":"7","key":"1009_CR12","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/17512433.2019.1621161","volume":"12","author":"NGL Jager","year":"2019","unstructured":"Jager NGL, et al. Antibiotic exposure at the site of infection: principles and assessment of tissue penetration. Expert Rev Clin Pharmacol. 2019;12(7):623\u201334. https:\/\/doi.org\/10.1080\/17512433.2019.1621161.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"10","key":"1009_CR13","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1021\/pr500587x","volume":"13","author":"T Bennike","year":"2014","unstructured":"Bennike T, et al. A normative study of the synovial fluid proteome from healthy porcine knee joints. J Proteome Res. 2014;13(10):4377\u201387. https:\/\/doi.org\/10.1021\/pr500587x.","journal-title":"J Proteome Res"},{"issue":"9","key":"1009_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/17425255.2022.2117607","volume":"18","author":"BCP Koch","year":"2022","unstructured":"Koch BCP, et al. The mysteries of target site concentrations of antibiotics in bone and joint infections: what is known? A narrative review. Expert Opin Drug Metab Toxicol. 2022;18(9):587\u2013600. https:\/\/doi.org\/10.1080\/17425255.2022.2117607.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"1009_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/j.1552-4604.1991.tb01892.x","volume":"31","author":"SR Cox","year":"1991","unstructured":"Cox SR, et al. Pharmacokinetics of the R(-) and S(+) enantiomers of ibuprofen in the serum and synovial fluid of arthritis patients. J Clin Pharmacol. 1991;31(1):88\u201394. https:\/\/doi.org\/10.1002\/j.1552-4604.1991.tb01892.x.","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"1009_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00228-020-03045-1","volume":"77","author":"M Asada","year":"2021","unstructured":"Asada M, et al. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery. Eur J Clin Pharmacol. 2021;77(5):735\u201345. https:\/\/doi.org\/10.1007\/s00228-020-03045-1.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"1009_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/jac\/dkm476","volume":"61","author":"JW Mouton","year":"2008","unstructured":"Mouton JW, et al. Tissue concentrations: do we ever learn? J Antimicrob Chemother. 2008;61(2):235\u20137. https:\/\/doi.org\/10.1093\/jac\/dkm476.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1009_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99162-7","volume":"11","author":"J Lanoiselee","year":"2021","unstructured":"Lanoiselee J, et al. Population pharmacokinetic model of cefazolin in total hip arthroplasty. Sci Rep. 2021;11(1):19763. https:\/\/doi.org\/10.1038\/s41598-021-99162-7.","journal-title":"Sci Rep"},{"issue":"3","key":"1009_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2106\/00004623-197860030-00016","volume":"60","author":"DJ Schurman","year":"1978","unstructured":"Schurman DJ, et al. Cefazolin concentrations in bone and synovial fluid. J Bone Joint Surg Am. 1978;60(3):359\u201362.","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"1009_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/00007691-200502000-00014","volume":"27","author":"PH Hinderling","year":"2005","unstructured":"Hinderling PH, Hartmann D. The pH dependency of the binding of drugs to plasma proteins in man. Ther Drug Monit. 2005;27(1):71\u201385. https:\/\/doi.org\/10.1097\/00007691-200502000-00014.","journal-title":"Ther Drug Monit"},{"issue":"2","key":"1009_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1302\/0301-620X.41B2.388","volume":"41-B","author":"EH Jebens","year":"1959","unstructured":"Jebens EH, Monk-Jones ME. On the viscosity and pH of synovial fluid and the pH of blood. J Bone Joint Surg Br. 1959;41-B(2):388\u2013400. https:\/\/doi.org\/10.1302\/0301-620X.41B2.388.","journal-title":"J Bone Joint Surg Br"},{"issue":"1","key":"1009_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/art.1780090106","volume":"9","author":"NA Cummings","year":"1966","unstructured":"Cummings NA, Nordby GL. Measurement of synovial fluid pH in normal and arthritic knees. Arthritis Rheum. 1966;9(1):47\u201356. https:\/\/doi.org\/10.1002\/art.1780090106.","journal-title":"Arthritis Rheum"},{"key":"1009_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212360","author":"P Beldowski","year":"2021","unstructured":"Beldowski P, et al. Albumin-hyaluronan interactions: influence of ionic composition probed by molecular dynamics. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222212360.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1009_CR24","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/bmc.3622","volume":"30","author":"SL Parker","year":"2016","unstructured":"Parker SL, et al. Determination of cefalothin and cefazolin in human plasma, urine and peritoneal dialysate by UHPLC-MS\/MS: application to a pilot pharmacokinetic study in humans. Biomed Chromatogr. 2016;30(6):872\u20139. https:\/\/doi.org\/10.1002\/bmc.3622.","journal-title":"Biomed Chromatogr"},{"issue":"10","key":"1009_CR25","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00228-011-1048-x","volume":"67","author":"S van Kralingen","year":"2011","unstructured":"van Kralingen S, et al. Pharmacokinetics and protein binding of cefazolin in morbidly obese patients. Eur J Clin Pharmacol. 2011;67(10):985\u201392. https:\/\/doi.org\/10.1007\/s00228-011-1048-x.","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"1009_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12121738","volume":"12","author":"SA Zelenitsky","year":"2023","unstructured":"Zelenitsky SA. Effective antimicrobial prophylaxis in surgery: the relevance and role of pharmacokinetics-pharmacodynamics. Antibiotics. 2023;12(12):1738. https:\/\/doi.org\/10.3390\/antibiotics12121738.","journal-title":"Antibiotics"},{"key":"1009_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jchromb.2014.05.021","volume":"961","author":"A Kratzer","year":"2014","unstructured":"Kratzer A, et al. Determination of free vancomycin, ceftriaxone, cefazolin and ertapenem in plasma by ultrafiltration: impact of experimental conditions. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;961:97\u2013102. https:\/\/doi.org\/10.1016\/j.jchromb.2014.05.021.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1009_CR28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jpba.2012.11.018","volume":"75","author":"C Wang","year":"2013","unstructured":"Wang C, Williams NS. A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds. J Pharm Biomed Anal. 2013;75:112\u20137. https:\/\/doi.org\/10.1016\/j.jpba.2012.11.018.","journal-title":"J Pharm Biomed Anal"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-026-01009-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-026-01009-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-026-01009-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:56:36Z","timestamp":1788980196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-026-01009-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1009"],"URL":"https:\/\/doi.org\/10.1007\/s13318-026-01009-x","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Thomas Pfeiffer receives research grants from Arthrex outside the submitted work. The other authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The datasets used during the current study are available from the corresponding author on reasonable request.","order":2,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the University of Witten\/Herdecke (Nr. 27\/2024 & 28\/2024).","order":3,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed written consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors contributed to the conception and design of the study. Sample collection and processing were performed by Steffen T. Ubl, Luc M.\u00a0Arnold, Thomas R. Pfeiffer, Arasch Wafaisade, Daniel Guenther, and the acknowledged surgeons. Sample analyses were conducted by Sophia Krombholz and Mario Thevis. Data processing and statistical analysis were led by Steffen T. Ubl and Sophia Krombholz. Steffen T. Ubl drafted the first version of the manuscript, and Sophia Krombholz and Luc M.\u00a0Arnold provided substantial revisions. All authors critically revised the manuscript, commented on previous versions, and approved the final manuscript.","order":7,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}